« Back
Home /
Tiplaxtinin

Tiplaxtinin

Manufacturer	MedChem Express
Category	Oncology Food Safety Proteins Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer Breast Cancer Uterine, Ovarian & Cervical Cancer
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	10mM/1mL
Item no.	HY-15253-10mM
Targets	PAI-1; Apoptosis
CASRN	393105-53-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Tiplaxtinin is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 μM[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	439.38
Clinical_Information	No Development Reported
Manufacturers Research_Area	Metabolic Disease; Cancer
Solubility	DMSO : 100 mg/mL (ultrasonic)\|H2O : < 0.1 mg/mL
Manufacturers Target	Apoptosis; PAI-1
Pathway	Apoptosis; Metabolic Enzyme/Protease
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-15253-10mM-safety-datasheet.pdf